These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 28161579)

  • 41. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
    Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
    Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine.
    Fernandez-Sainz I; Medina GN; Ramirez-Medina E; Koster MJ; Grubman MJ; de Los Santos T
    Virology; 2017 Feb; 502():123-132. PubMed ID: 28039799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of synthetic peptide candidate vaccines against serotype-A foot-and-mouth disease virus in cattle.
    Zhang Z; Pan L; Ding Y; Zhou P; Lv J; Chen H; Fang Y; Liu X; Chang H; Zhang J; Shao J; Lin T; Zhao F; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2015 Feb; 99(3):1389-98. PubMed ID: 25381487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Robust Protection against Highly Virulent Foot-and-Mouth Disease Virus in Swine by Combination Treatment with Recombinant Adenoviruses Expressing Porcine Alpha and Gamma Interferons and Multiple Small Interfering RNAs.
    Kim SM; Park JH; Lee KN; Kim SK; You SH; Kim T; Tark D; Lee HS; Seo MG; Kim B
    J Virol; 2015 Aug; 89(16):8267-79. PubMed ID: 26041279
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A foot-and-mouth disease SAT2 vaccine protects swine against experimental challenge with a homologous virus strain, irrespective of mild pathogenicity in this species.
    Mouton L; Dekker A; Bleijenberg M; Blanchet M; Coco-Martin J; Hudelet P; Goutebroze S
    Vaccine; 2018 Apr; 36(15):2020-2024. PubMed ID: 29510916
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunogenicity and protective efficacy of 3A truncated negative marker foot-and-mouth disease virus serotype A vaccine.
    Dhanesh VV; Hosamani M; Basagoudanavar SH; Saravanan P; Biswal JK; Tamil Selvan RP; Madhavan A; Sehrish K; Sanyal A; Sreenivasa BP
    Appl Microbiol Biotechnol; 2020 Mar; 104(6):2589-2602. PubMed ID: 32002597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular vaccine prepared by fusion of XCL1 to the multi-epitope protein of foot-and-mouth disease virus enhances the specific humoural immune response in cattle.
    Li K; Bao H; Wei G; Li D; Chen Y; Fu Y; Cao Y; Li P; Sun P; Bai X; Ma X; Zhang J; Lu Z; Liu Z
    Appl Microbiol Biotechnol; 2017 Nov; 101(21):7889-7900. PubMed ID: 28929328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenic evaluation of FMD virus immuno-dominant epitopes coupled with IL-2/FcIgG in BALB/c mice.
    Doosti M; Nassiri M; Nasiri K; Tahmoorespur M; Zibaee S
    Microb Pathog; 2019 Jul; 132():30-37. PubMed ID: 31004723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BacMam Expressing Highly Glycosylated Porcine Interferon Alpha Induces Robust Antiviral and Adjuvant Effects against Foot-and-Mouth Disease Virus in Pigs.
    Kim A; Lee G; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM
    J Virol; 2022 Jun; 96(12):e0052822. PubMed ID: 35604219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
    Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
    Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early protection in sheep against intratypic heterologous challenge with serotype O foot-and-mouth disease virus using high-potency, emergency vaccine.
    Horsington J; Zhang Z; Bittner H; Hole K; Singanallur NB; Alexandersen S; Vosloo W
    Vaccine; 2015 Jan; 33(3):422-9. PubMed ID: 25483241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjuvants for foot-and-mouth disease virus vaccines: recent progress.
    Cao Y
    Expert Rev Vaccines; 2014 Nov; 13(11):1377-85. PubMed ID: 25234962
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Needleless intradermal vaccination for foot-and-mouth disease induced granuloma-free effective protection in pigs.
    Hwang JH; Lee KN; Kim SM; Lee G; Moon Y; Kim B; Lee JS; Park JH
    J Vet Sci; 2019 May; 20(3):e29. PubMed ID: 31161747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Constitutively Active IRF7/IRF3 Fusion Protein Completely Protects Swine against Foot-and-Mouth Disease.
    Ramírez-Carvajal L; Diaz-San Segundo F; Ramirez-Medina E; Rodríguez LL; de Los Santos T
    J Virol; 2016 Oct; 90(19):8809-21. PubMed ID: 27466421
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation of synthetic peptide vaccines against foot-and-mouth disease type A].
    Tang H; Liu X; Fang Y; Jiang S; Pan L; Lv J; Zhang Z; Zhou P; Zhang Y; Wang Y
    Wei Sheng Wu Xue Bao; 2013 Jun; 53(6):596-607. PubMed ID: 24028062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sindbis virus replicase-based DNA vaccine construct encoding FMDV-specific multivalent epitope gene: studies on its immune responses in guinea pigs.
    Dar PA; Ganesh K; Nagarajan G; Sarika S; Reddy GR; Suryanarayana VV
    Scand J Immunol; 2012 Oct; 76(4):345-53. PubMed ID: 22702835
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunogenicity and protective efficacy of a novel foot-and-mouth disease virus empty-capsid-like particle with improved acid stability.
    Xie Y; Li H; Qi X; Ma Y; Yang B; Zhang S; Chang H; Yin X; Li Z
    Vaccine; 2019 Mar; 37(14):2016-2025. PubMed ID: 30808570
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D.
    García-Briones MM; Blanco E; Chiva C; Andreu D; Ley V; Sobrino F
    Virology; 2004 May; 322(2):264-75. PubMed ID: 15110524
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.
    Medina GN; Montiel N; Diaz-San Segundo F; Sturza D; Ramirez-Medina E; Grubman MJ; de los Santos T
    Clin Vaccine Immunol; 2015 Nov; 23(2):125-36. PubMed ID: 26607309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.